These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 32095437)

  • 1. Reverse vaccinology approach for the identification and characterization of outer membrane proteins of
    Leow CY; Kazi A; Hisyam Ismail CMK; Chuah C; Lim BH; Leow CH; Banga Singh KK
    Clin Exp Vaccine Res; 2020 Jan; 9(1):15-25. PubMed ID: 32095437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mass spectrometry-based immunopeptidomics and computational vaccinology strategies for the identification of universal Shigella immunogenic candidates.
    Mohammad Shabani NR; Khairul Hisyam Ismail CM; Anthony AA; Leow CH; Chuah C; Abdul Majeed AB; Nor NM; He Y; Banga Singh KK; Leow CY
    Comput Biol Med; 2022 Sep; 148():105900. PubMed ID: 35952542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and evaluation of novel vaccine candidates against Shigella flexneri through reverse vaccinology approach.
    Hajialibeigi A; Amani J; Gargari SLM
    Appl Microbiol Biotechnol; 2021 Feb; 105(3):1159-1173. PubMed ID: 33452891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global burden of Shigella infections: implications for vaccine development and implementation of control strategies.
    Kotloff KL; Winickoff JP; Ivanoff B; Clemens JD; Swerdlow DL; Sansonetti PJ; Adak GK; Levine MM
    Bull World Health Organ; 1999; 77(8):651-66. PubMed ID: 10516787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of vaccine and drug targets in Shigella dysenteriae sd197 using reverse vaccinology approach.
    Jalal K; Abu-Izneid T; Khan K; Abbas M; Hayat A; Bawazeer S; Uddin R
    Sci Rep; 2022 Jan; 12(1):251. PubMed ID: 34997046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outer Membrane Vesicles Derived from
    Tian H; Li B; Xu T; Yu H; Chen J; Yu H; Li S; Zeng L; Huang X; Liu Q
    Appl Environ Microbiol; 2021 Sep; 87(19):e0096821. PubMed ID: 34319809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Towards a peptide-based vaccine against Shigella sonnei: A subtractive reverse vaccinology based approach.
    Baseer S; Ahmad S; Ranaghan KE; Azam SS
    Biologicals; 2017 Nov; 50():87-99. PubMed ID: 28826780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative proteomic analysis of Shigella flexneri and Shigella sonnei Generalized Modules for Membrane Antigens (GMMA) reveals highly pure preparations.
    Maggiore L; Yu L; Omasits U; Rossi O; Dougan G; Thomson NR; Saul A; Choudhary JS; Gerke C
    Int J Med Microbiol; 2016 Feb; 306(2):99-108. PubMed ID: 26746581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shigellosis.
    Niyogi SK
    J Microbiol; 2005 Apr; 43(2):133-43. PubMed ID: 15880088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of Reverse Vaccinology and Immunoinformatic Strategies for the Identification of Vaccine Candidates Against Shigella flexneri.
    Leow CY; Chuah C; Abdul Majeed AB; Mohd Nor N; Leow CH
    Methods Mol Biol; 2022; 2414():17-35. PubMed ID: 34784029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shigella isolates from the global enteric multicenter study inform vaccine development.
    Livio S; Strockbine NA; Panchalingam S; Tennant SM; Barry EM; Marohn ME; Antonio M; Hossain A; Mandomando I; Ochieng JB; Oundo JO; Qureshi S; Ramamurthy T; Tamboura B; Adegbola RA; Hossain MJ; Saha D; Sen S; Faruque AS; Alonso PL; Breiman RF; Zaidi AK; Sur D; Sow SO; Berkeley LY; O'Reilly CE; Mintz ED; Biswas K; Cohen D; Farag TH; Nasrin D; Wu Y; Blackwelder WC; Kotloff KL; Nataro JP; Levine MM
    Clin Infect Dis; 2014 Oct; 59(7):933-41. PubMed ID: 24958238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shigella flexneri 3a outer membrane protein C epitope is recognized by human umbilical cord sera and associated with protective activity.
    Jarząb A; Witkowska D; Ziomek E; Dąbrowska A; Szewczuk Z; Gamian A
    PLoS One; 2013; 8(8):e70539. PubMed ID: 23940590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multi-serotype outer membrane vesicles of Shigellae confer passive protection to the neonatal mice against shigellosis.
    Mitra S; Chakrabarti MK; Koley H
    Vaccine; 2013 Jun; 31(31):3163-73. PubMed ID: 23684822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Designing and evaluation of an antibody-targeted chimeric recombinant vaccine encoding Shigella flexneri outer membrane antigens.
    Kazi A; Hisyam Ismail CMK; Anthony AA; Chuah C; Leow CH; Lim BH; Banga Singh KK; Leow CY
    Infect Genet Evol; 2020 Jun; 80():104176. PubMed ID: 31923724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In silico design of a vaccine candidate based on autotransporters and HSP against the causal agent of shigellosis, Shigella flexneri.
    León Y; Zapata L; Salas-Burgos A; Oñate A
    Mol Immunol; 2020 May; 121():47-58. PubMed ID: 32163758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and evaluation of a Shigella flexneri 2a and S. sonnei bivalent invasin complex (Invaplex) vaccine.
    Oaks EV; Turbyfill KR
    Vaccine; 2006 Mar; 24(13):2290-301. PubMed ID: 16364513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stable Chromosomal Expression of Shigella flexneri 2a and 3a O-Antigens in the Live Salmonella Oral Vaccine Vector Ty21a.
    Dharmasena MN; Osorio M; Takeda K; Stibitz S; Kopecko DJ
    Clin Vaccine Immunol; 2017 Dec; 24(12):. PubMed ID: 29046309
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Clarkson KA; Porter CK; Talaat KR; Frenck RW; Alaimo C; Martin P; Bourgeois AL; Kaminski RW
    mSphere; 2021 Aug; 6(4):e0012221. PubMed ID: 34259559
    [No Abstract]   [Full Text] [Related]  

  • 19. Computational characterization of epitopic region within the outer membrane protein candidate in
    Bhattacharya M; Malick RC; Mondal N; Patra P; Pal BB; Patra BC; Kumar Das B
    J Biomol Struct Dyn; 2020 Feb; 38(2):450-459. PubMed ID: 30744535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential Outer Membrane Protein Candidates for Vaccine Development Against the Pathogen Vibrio anguillarum: A Reverse Vaccinology Based Identification.
    Baliga P; Shekar M; Venugopal MN
    Curr Microbiol; 2018 Mar; 75(3):368-377. PubMed ID: 29119233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.